Skip to content
WeighLab
Menu
Ranked #273 · Grade C

Form Health review

Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

Visit Form Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$1,350/mo (starting dose, brand-name)
Tirzepatide
$1,350/mo (starting dose, brand-name)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$16,200

Tirzepatide · modeled / year

$16,200

The Index scorecard

Form Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month36/100
Price Transparency30/100
Nationwide Access86/100
Formulation Options79/100
Clinical Oversight85/100
Contract Flexibility41/100

Where the value is

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

The tradeoffs

  • Higher brand-name pricing only
  • Premium pricing relative to market

The bottom line

Best for: Cost-first shoppers who want comprehensive concierge care. Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

Ranked #273 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Form Health.

The 18 programs nearest this one

Pricing, states and verification reflect Form Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Form Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard